FTT PET/CT in Pancreatic Neuroendocrine Tumors

Clinical trial NCT07114939 · RECRUITING

Trial details

NCT number: NCT07114939
Sponsor: Abramson Cancer Center at Penn Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Neuroendocrine Carcinoma Metastatic Pancreatic Tumors

Start date: 2025-10-01
Primary completion: 2027-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.